Viewing Study NCT02197650


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2025-12-28 @ 2:11 PM
Study NCT ID: NCT02197650
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2018-12-04
First Post: 2014-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase
Sponsor: ERYtech Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module